Related Experiment Video
Updated: Apr 8, 2026

Identification of Homologous Recombination Events in Mouse Embryonic Stem Cells Using Southern Blotting and Polymerase Chain Reaction
Published on: November 20, 2018
129-Derived Mouse Strains Express an Unstable but Catalytically Active DNA Polymerase Iota Variant
Said Aoufouchi1, Annie De Smet2, Frédéric Delbos2
1Centre National de la Recherche Scientifique UMR 8200, Institut Gustave Roussy, Villejuif, and Université Paris-Sud, Orsay, France said.aoufouchi@gustaveroussy.fr.
Abstract:
Mice derived from the 129 strain have a nonsense codon mutation in exon 2 of the polymerase iota (Polι) gene and are therefore considered Polι deficient. When we amplified Polι mRNA from 129/SvJ or 129/Ola testes, only a small fraction of the full-length cDNA contained the nonsense mutation; the major fraction corresponded to a variant Polι isoform lacking exon 2. Polι mRNA lacking exon 2 contains an open reading frame, and the corresponding protein was detected using a polyclonal antibody raised against the C terminus of the murine Polι protein. The identity of the corresponding protein was further confirmed by mass spectrometry. Although the variant protein was expressed at only 5 to 10% of the level of wild-type Polι, it retained de novo DNA synthesis activity, the capacity to form replication foci following UV irradiation, and the ability to rescue UV light sensitivity in Polι(-/-) embryonic fibroblasts derived from a new, fully deficient Polι knockout (KO) mouse line. Furthermore, in vivo treatment of 129-derived male mice with Velcade, a drug that inhibits proteasome function, stabilized and restored a substantial amount of the variant Polι in these animals, indicating that its turnover is controlled by the proteasome. An analysis of two xeroderma pigmentosum-variant (XPV) cases corresponding to missense mutants of Polη, a related translesion synthesis (TLS) polymerase in the same family, similarly showed a destabilization of the catalytically active mutant protein by the proteasome. Collectively, these data challenge the prevailing hypothesis that 129-derived strains of mice are completely deficient in Polι activity. The data also document, both for 129-derived mouse strains and for some XPV patients, new cases of genetic defects corresponding to the destabilization of an otherwise functional protein, the phenotype of which is reversible by proteasome inhibition.
Insights
Mice thought to be deficient in polymerase iota (Polι) actually produce a functional variant protein. This variant
Area of Science:
- Molecular Biology
- Genetics
- Biochemistry
Background:
- Mice from the 129 strain harbor a mutation in the polymerase iota (Polι) gene, leading to the assumption of Polι deficiency.
- This deficiency has implications for understanding DNA repair mechanisms and genetic disease models.
Purpose of the Study:
- To investigate the actual Polι activity in 129 strain mice.
- To characterize the variant Polι isoform and its functional capabilities.
- To explore the role of proteasome degradation in Polι stability and potential therapeutic interventions.
Main Methods:
- Amplification and sequencing of Polι mRNA from 129 mouse testes.
- Protein detection using polyclonal antibodies and mass spectrometry.
- Functional assays including de novo DNA synthesis and UV sensitivity rescue in knockout cells.
- In vivo treatment with Velcade (proteasome inhibitor) and analysis of xeroderma pigmentosum-variant (XPV) cases.
Main Results:
- A major fraction of Polι mRNA in 129 mice encodes a variant isoform lacking exon 2.
- This variant Polι protein, though at lower levels, retains DNA synthesis and UV repair capabilities.
- Proteasome inhibition stabilizes the variant Polι, suggesting its turnover is proteasome-dependent.
- Similar proteasome-mediated destabilization was observed in XPV patients with Polη mutations.
Conclusions:
- 129-derived mice are not completely deficient in Polι activity; a functional variant exists.
- Genetic defects involving protein destabilization, reversible by proteasome inhibition, are identified in both mouse models and XPV patients.
- This challenges existing hypotheses and opens new avenues for understanding and potentially treating genetic disorders related to DNA repair polymerases.
Related Concept Videos
In-vitro Mutagenesis
Proofreading
Errors During Replication are Corrected by the DNA Polymerase...
Proofreading
Eukaryotic RNA Polymerases
All three eukaryotic RNAPs require specific transcription factors, of which the...
Translesion DNA Polymerases
TLS polymerases are found in all three domains of life - archaea, bacteria, and eukaryotes. Of the different classes of TLS polymerases, members of the Y family are fitted with specialized structures that...
Mismatch Repair
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...

